0
Skip to Content
Reid Robison
About
Work
Highlights
Archive
Publications
Art
Events
Podcast
Reid Robison
About
Work
Highlights
Archive
Publications
Art
Events
Podcast
About
Folder: Work
Back
Highlights
Archive
Publications
Art
Events
Podcast
Date
  • 2015
  • 2016
  • 2017
  • 2018
  • 2020
  • 2021
  • 2022
  • 2023
Topic
  • Anxiety
  • Ayahuasca
  • Depression
  • Eating disorders
  • Esketamine
  • Ketamine
  • LSD
  • MDMA
  • Mindfulness
  • Psilocybin
  • Psychedelics
  • Therapy
  • Trauma
  • Yoga
Category
  • Article
  • Blog
  • Interview
  • Panel
  • Podcast
  • Presentation
  • Press Release
  • Publication
  • Video
  • Webinar
Smithsonian Magazine: Are psychedelics the future of eating disorder treatment?
Article, Interview Reid Robison, MD MBA 11/18/23 Article, Interview Reid Robison, MD MBA 11/18/23

Smithsonian Magazine: Are psychedelics the future of eating disorder treatment?

Read More
Psychedelics Avant-gardes: Research, Therapies & Regulations
Webinar, Presentation Reid Robison, MD MBA 10/20/23 Webinar, Presentation Reid Robison, MD MBA 10/20/23

Psychedelics Avant-gardes: Research, Therapies & Regulations

Read More
Tricycle Day: Psychonaut POV — Q&A with Reid Robison
Article, Interview Reid Robison, MD MBA 10/9/23 Article, Interview Reid Robison, MD MBA 10/9/23

Tricycle Day: Psychonaut POV — Q&A with Reid Robison

Read More
Single-dose psilocybin treatment for MDD: A randomized clinical trial
Publication Reid Robison, MD MBA 9/5/23 Publication Reid Robison, MD MBA 9/5/23

Single-dose psilocybin treatment for MDD: A randomized clinical trial

JAMA Psychiatry | Published 5 Sep 2023

Read More
Everyday Health: What is ketamine therapy? A detailed scientific guide
Article, Interview Reid Robison, MD MBA 8/18/23 Article, Interview Reid Robison, MD MBA 8/18/23

Everyday Health: What is ketamine therapy? A detailed scientific guide

Read More
Forbes Health: Ketamine for depression — Does it work?
Article Reid Robison, MD MBA 8/8/23 Article Reid Robison, MD MBA 8/8/23

Forbes Health: Ketamine for depression — Does it work?

Read More
Salt Lake Tribune: Utah failed to legalize psilocybin—but local research, and an underground scene, is booming
Article Reid Robison, MD MBA 7/3/23 Article Reid Robison, MD MBA 7/3/23

Salt Lake Tribune: Utah failed to legalize psilocybin—but local research, and an underground scene, is booming

Read More
Case report: IM ketamine or IN esketamine as a treatment in four patients with MDD & comorbid anorexia
Publication Reid Robison, MD MBA 5/18/23 Publication Reid Robison, MD MBA 5/18/23

Case report: IM ketamine or IN esketamine as a treatment in four patients with MDD & comorbid anorexia

Front Psychiatry | Published 15 May 2023

Read More
Group KAP for healthcare workers with COVID-19 related burnout & PTSD: A case series
Publication Reid Robison, MD MBA 3/2/23 Publication Reid Robison, MD MBA 3/2/23

Group KAP for healthcare workers with COVID-19 related burnout & PTSD: A case series

J Psychoact Drugs | Published 2 Mar 2023

Read More
Daily Hive: We asked an expert to explain psychedelic-assisted therapy
Article, Interview Reid Robison, MD MBA 11/30/22 Article, Interview Reid Robison, MD MBA 11/30/22

Daily Hive: We asked an expert to explain psychedelic-assisted therapy

Read More
Salt Lake Tribune: A framework for safe access to psychotherapeutic medicine in Utah
Article Reid Robison, MD MBA 11/18/22 Article Reid Robison, MD MBA 11/18/22

Salt Lake Tribune: A framework for safe access to psychotherapeutic medicine in Utah

Read More
Real world study: Safety & effectiveness of IN esketamine for treatment-resistant depression
Publication Reid Robison, MD MBA 11/4/22 Publication Reid Robison, MD MBA 11/4/22

Real world study: Safety & effectiveness of IN esketamine for treatment-resistant depression

J Comp Eff Res | 4 Nov 2022

Read More
Real-world depression, anxiety & safety outcomes of IM ketamine: a retrospective cohort study
Publication Reid Robison, MD MBA 10/3/22 Publication Reid Robison, MD MBA 10/3/22

Real-world depression, anxiety & safety outcomes of IM ketamine: a retrospective cohort study

BMC Psychiatry | Published 3 Oct 2022

Read More
Cost-effectiveness of esketamine nasal spray compared to IV ketamine
Publication Reid Robison, MD MBA 9/23/22 Publication Reid Robison, MD MBA 9/23/22

Cost-effectiveness of esketamine nasal spray compared to IV ketamine

J Affect Disord | Published 23 Sep 2022

Read More
HCPLive Symposium: Addressing challenges in depression treatment
Presentation Reid Robison, MD MBA 9/9/22 Presentation Reid Robison, MD MBA 9/9/22

HCPLive Symposium: Addressing challenges in depression treatment

Read More
Psychiatric Times: The potential of psychedelics
Interview Reid Robison, MD MBA 8/11/22 Interview Reid Robison, MD MBA 8/11/22

Psychiatric Times: The potential of psychedelics

Read More
Kind Magazine: What a long, strange trip it’s been
Article Reid Robison, MD MBA 7/13/22 Article Reid Robison, MD MBA 7/13/22

Kind Magazine: What a long, strange trip it’s been

Read More
Psychedelics Today: Ketamine-assisted psychotherapy, therapist burnout, & LSD for Anxiety
Podcast Reid Robison, MD MBA 5/31/22 Podcast Reid Robison, MD MBA 5/31/22

Psychedelics Today: Ketamine-assisted psychotherapy, therapist burnout, & LSD for Anxiety

Read More
Utah Fungi Festival Talk: How might psilocybin change your mind
Presentation Reid Robison, MD MBA 5/15/22 Presentation Reid Robison, MD MBA 5/15/22

Utah Fungi Festival Talk: How might psilocybin change your mind

Read More
Case series: Group KAP for eating disorder patients with comorbid depression & anxiety
Publication Reid Robison, MD MBA 5/6/22 Publication Reid Robison, MD MBA 5/6/22

Case series: Group KAP for eating disorder patients with comorbid depression & anxiety

J Eat Disord | Published 6 May 2022

Read More
Older Posts

About

HIGHLIGHTS

BLOG

PUBLICATIONS

Podcast

Contact

Numinus ↗

Cedar Clinical Research ↗

Psychedelic Institute ↗

Stay in the loop

Sign up with your email address to receive news and updates.

Thank you!